As reported, Maackiain can dampen human monoamine oxidase B (MAO‐B) enzyme for the treatment of disorders like Alzheimer disease, Parkinson's disease and depression.18 This evidence concerns the gene MAOB and early-onset autosomal dominant Alzheimer disease.